Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94

Go back to Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
(NYSE: CLDI) Delayed: 1.60 +0.06 (3.90%)
Previous Close $1.54    52 Week High
Open $1.50    52 Week Low
Day High $1.63    P/E N/A 
Day Low $1.50    EPS
Volume 120,735